Orchid says US FDA has closed PADE inspection 09-Jan-2018 By Staff reporter Orchid Pharma Ltd has received an Establishment Inspection Report (EIR) from the US FDA for its Chennai facility.
News in Brief US FDA inspection lands Glenmark with 483 with seven observations 28-Nov-2017 By Dan Stanton Glenmark has received a US FDA Form 483 with seven observations at its Baddi finished formulations facility in Baddi, India.
Biocon all clear, Dr Reddy's stays under scrutiny: US FDA Indian audit round-up 23-Nov-2017 By Dan Stanton The US FDA has issued Establishment Inspection Reports (EIRs) closing out inspections at Biocon’s biomanufacturing plant in Bangalore and a Divi’s Lab facility in Visakhapatnam.
Sun says US FDA has issued an EIR for Dadra API plant 17-Oct-2017 By Gareth Macdonald Sun Pharmaceutical Industries Ltd says the US FDA has issued it with an enforcement inspection report (EIR) for its facility in Dadra.
Jubilant denies speculation it will sell its fine chemical business 06-Feb-2014 Jubilant Life Sciences has dismissed claims it is looking to sell off its fine chemicals business.
Ranbaxy to Invest $35m in Second Malaysian Facility 08-Aug-2013 By Dan Stanton Sales and profit were down in Q2 for Ranbaxy but the firm has signed an agreement with the Malaysian Government to build a new manufacturing facility.
Strike Ends at Shasun API Plant but Share Price Takes Hit 02-Jul-2013 Operations have restarted at one of Shasun’s API facilities in India following a strike last month.
Elder Pharma wants to make pile from EU Diosmin API sales 13-Nov-2012 Elder Pharma hopes to increase sales to European drugmakers after receiving a certificate of suitability (CEP) for the API Diosmin.
Fire at Aurobindo API plant injures three, operations unaffected Fire at Aurobindo API plant injures three, operations unaffected 30-Nov-2011 By Gareth Macdonald Aurobindo Pharma says a fire that broke out at its manufacturing plant in India injuring three employees did not disrupt production operations.